key: cord-0071579-mjn5bna0
authors: nan
title: African Vaccination Figures
date: 2021-10-11
journal: nan
DOI: 10.1111/j.1467-6346.2021.10190.x
sha: 231e9795d1a4149f55da19457ae1d4b8b1f1f729
doc_id: 71579
cord_uid: mjn5bna0

nan

Instead of committing to measurable actions and financial contributions, successive G7 and G20 summits have lamented the deadly inequities in vaccine distribution and made general statements of concern. On September 6th in Rome, G20 officials said "the strongest countries . . . [were] committed to investing significant resources and sending vaccines to the most fragile. . ." When asked for specifics, Italy's Health Minister Roberto Speranza said such 'pledges' risked being a 'straitjacket' but their priority was the 'political goal' of global vaccination. Speranza held out the prospect of some practical commitments being made at a meeting of G20 finance and health ministers in October. The EU says that it will provide financial support under its clunkily named 'Team Europe' to fund three vaccine hubs in Africa. Eventually, wider vaccine and pharmaceutical production facilities could take place at the hubs.

The move comes shortly after a row over the export of Covid-19 vaccines bottled in South Africa to Europe and repeated accusations by African leaders of Western 'vaccine nationalism'. The European Commission maintains that the South African contract was part of a wider EU plan to promote investment in vaccine hubs, but the arrangement was condemned by WHO director general Tedros Adhanom Ghebreyesus. The rejection by G20 countries of a proposal by India and South Africa at the World Trade Organisation (WTO) to partially waive the agreement on intellectual property rights on vaccines has also caused ill-feeling. However, this is a long-term project. BioNTech's Chief Executive U gur S ßahin has been clear that the first priority at the two sites is to manufacture malaria and tuberculosis vaccines, rather than Covid shots. No date has yet been confirmed for when manufacturing will start.

The malaria and TB treatments would be based on the so-called messenger RNA technology, which is used by BioNTech in its Covid-19 vaccine In the meantime, the African CDC and AU want to move ahead with a proposed African Medicines Agency, an AU agency intended to facilitate the harmonisation of medical regulation across the continent. (Africa Confidential 7/9)

Algeria: On September 5th, Algeria received 2m doses of a Covid-19 vaccine it had purchased from China, the Defence Ministry announced. The ministry statementreported by Ennahar websitesaid that a military aircraft carrying the doses had arrived at Boufarik air base, west of the capital Algiers. This shipment will be followed by more batches of Covid-19 vaccines, which will arrive over the coming weeks as a support for the national health care system. 

South Africa: 11.24% eSwatini: 9

Sao Tome e Principe: 5.33% Namibia: 4.47%

Djibouti: 2.37%

Malawi: 2.22% Mozambique: 2.03%